Get started
Author

Carl M. Hay

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
1997 · Derek L. Choi-Lundberg, Qing Lin, et al. · Science · 625
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
2016 · Arabella Young, Shin Foong Ngiow, et al. · Cancer Cell · 393
PDF
Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus
2008 · Laura M. Hales, Nick J. Knowles, et al. · Journal of General Virology · 377
Targeting CD73 in the tumor microenvironment with MEDI9447
2016 · Carl M. Hay, Erin Sult, et al. · OncoImmunology · 297
Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers
2007 · P. Seshidhar Reddy, Kevin D. Burroughs, et al. · JNCI Journal of the National Cancer Institute · 242
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
2020 · Rui Yang, Samah Elsaadi, et al. · Journal for ImmunoTherapy of Cancer · 134
PDF
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
2003 · John L Jakubczak, Patricia Ryan, et al. · PubMed · 99
Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
2013 · Steven Rust, Sandrine Guillard, et al. · Molecular Cancer · 56
PDF
Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling
2015 · Alan M. Sandercock, Steven Rust, et al. · Molecular Cancer · 53
PDF
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer
2004 · Patricia C Ryan, John L Jakubczak, et al. · Cancer Gene Therapy · 41
Systemic Gene-Directed Enzyme Prodrug Therapy of Hepatocellular Carcinoma Using a Targeted Adenovirus Armed with Carboxypeptidase G2
2005 · Silke Schepelmann, Paul Hallenbeck, et al. · Cancer Research · 32
Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob
2001 · Carl M. Hay, Hector de Leon, et al. · Journal of Vascular Research · 30
Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases
2017 · Dipti Vijayan, Deborah S. Barkauskas, et al. · OncoImmunology · 28
PDF
Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression
2017 · Alexandra Borodovsky, Yanjun Wang, et al. · Cancer Research · 24
Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening
2012 · Kris F. Sachsenmeier, Carl Hay, et al. · SLAS DISCOVERY · 23
Development of a Trispecific Antibody Designed to Simultaneously and Efficiently Target Three Different Antigens on Tumor Cells
2015 · Nazzareno Dimasi, Ryan Fleming, et al. · Molecular Pharmaceutics · 22
Differential Cell Cycle Progression Patterns of Infiltrating Leukocytes and Resident Cells After Balloon Injury of the Rat Carotid Artery
2001 · Carl Hay, Connie Micko, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 22
PDF
Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models
2018 · Alexandra Borodovsky, Yanjun Wang, et al. · Cancer Research · 11
Abstract 285: MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment
2015 · Carl Hay, Erin Sult, et al. · Cancer Research · 10
Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain
2017 · Nazzareno Dimasi, Ryan Fleming, et al. · mAbs · 8
PDF
Preclinical Analyses Support Clinical Investigation of Combined PD-L1 Blockade and Anti-CD19 CAR T Cell Therapy for the Treatment of NHL
2015 · Ryan P Larson, Michael Ports, et al. · Blood · 4
Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma
2018 · Rui Yang, Samah Elsaadi, et al. · Cancer Research · 3
Retracted
2020 · Samah Elsaadi, Kristine Misund, et al. · Journal for ImmunoTherapy of Cancer
PDF
Immunosuppressive adenosine - a novel treatment target for multiple myeloma
2019 · Rui Yang, Samah Elsaadi, et al. · Clinical Lymphoma Myeloma & Leukemia
Abstract 272: Checkpoint inhibitor combinations in a human mixed leukocyte reaction
2015 · Erin Sult, Carl Hay, et al. · Cancer Research
Works count: 30
Citation count: 2,534
H-index: 17
I10-index: 19
Year
Topic
Type